Protein ubiquitination is one of the most powerful posttranslational modifications of proteins, as it regulates a plethora of cellular processes in distinct manners. Simple monoubiquitination events coexist with more complex forms of polyubiquitination, the latter featuring many different chain architectures. Ubiquitin can be subjected to further posttranslational modifications (e.g., phosphorylation and acetylation) and can also be part of mixed polymers with ubiquitin-like modifiers such as SUMO (small ubiquitinrelated modifier) or NEDD8 (neural precursor cell expressed, developmentally downregulated 8). Together, cellular ubiquitination events form a sophisticated and versatile ubiquitin code. Deubiquitinases (DUBs) reverse ubiquitin signals with equally high sophistication. In this review, we conceptualize the many layers of specificity that DUBs encompass to control the ubiquitin code and discuss examples in which DUB specificity has been understood at the molecular level. We further discuss the many mechanisms of DUB regulation with a focus on those that modulate catalytic activity. Our review provides a framework to tackle lingering questions in DUB biology.
THE UBIQUITIN CODE
The ubiquitin system is a universal means to regulate protein function. The vast majority of cellular proteins are ubiquitinated during their lifetime. In most cases, ubiquitination occurs at the end of a protein's existence, as ubiquitin attachment most commonly initiates protein degradation, for example, by the proteasome (1) . In addition, an ever-growing number of nondegradative ubiquitination events exist, and it is now clear that most cellular processes utilize ubiquitination (2) (3) (4) . The pervasive roles of ubiquitination are further illustrated by the tens of thousands of ubiquitination sites that can be detected in mammalian cells (5) (6) (7) . Hence, just like other wellstudied regulatory posttranslational modifications (PTMs) such as protein phosphorylation, the ubiquitin system is vast and impacts all aspects of cellular life.
Whereas protein phosphorylation produces a binary on-off signal, ubiquitination is remarkably tunable, and many layers of complexity are still emerging, even 30 years after its discovery (4) . There are many types of ubiquitination, but the principal and most abundant forms are monoubiquitination as well as Lys48-linked and Lys63-linked polyubiquitination (Figure 1a ) (5) . In the latter, ubiquitin molecules have been ubiquitinated on Lys48 or Lys63, respectively, forming a chain of one linkage type (a so-called homotypic ubiquitin chain). Importantly, the outcomes of these different ubiquitination events for the substrate are distinct: Monoubiquitination may facilitate protein recognition, complex formation, or allosteric regulation, whereas Lys48-linked polyubiquitin is a signal for proteasomal degradation. In contrast, Lys63-linked chains have nondegradative roles in cellular signaling, intracellular trafficking, the DNA damage response, and other contexts (2) (3) (4) .
Ubiquitin has eight ubiquitination sites-seven lysine residues as well as a primary amine at the N terminus-all of which can participate in polyubiquitin chain formation (Figure 1b) , and roles for other, so-called atypical chain types are emerging (2) (3) (4) Second, a new layer of cross talk emerges between ubiquitin and small chemical PTMs such as phosphorylation and acetylation (Figure 1b) . Ubiquitin contains 11 serine, threonine, and tyrosine residues, and mass spectrometry studies have found that each residue can be phosphorylated in cells (16, 17 ) (see also PhosphoSitePlus at http://www.phosphosite.org). Recent work has linked Ser65 phosphoubiquitin to mitophagy, a process mediating the demise of damaged mitochondria by autophagy (18, 19) . In addition to phosphorylation, ubiquitin can also be acetylated on lysine residues (20) , and other ubiquitin modifications likely exist. Any PTM on ubiquitin may change its properties [e.g., Ser65 phosphorylation induces a conformational change (21) ], which could affect chain formation, and may prevent or facilitate ubiquitin interactions (21, 22) .
The ubiquitin code hence provides a plethora of distinct signals that are used in different functional contexts (2) (3) (4) . Specific signaling requires equally sophisticated mechanisms of regulation. Deubiquitinases (DUBs) play an important part in regulating the many layers of the ubiquitin code and are the focus of this review.
DEALING WITH COMPLEXITY: PLAYERS OF THE UBIQUITIN SYSTEM
Ubiquitin signals are assembled by an enzymatic cascade involving E1 ubiquitin-activating enzymes (23) , E2 ubiquitin-conjugating enzymes (24) , and E3 ubiquitin ligases (25) . Many E2 and E3 enzymes generate ubiquitin chains and determine the architecture within polyubiquitin modifications (Figure 2) . The distinct signals are recognized by ubiquitin receptors that contain one or several ubiquitin-binding domains (UBDs) (26) .
The removal of ubiquitin signals is performed by DUBs, which deal with the vast complexity of the ubiquitin system (27) (28) (29) . The number of DUBs varies in different organisms; for example, ∼20 DUBs exist in Saccharomyces cerevisiae, contrasted with ∼100 enzymes in humans (27) (28) (29) . To date, six structurally distinct DUB families have been described. These include five families of cysteine proteases (Figure 2) : the ubiquitin-specific proteases (USPs; 54 members in humans), the ovarian tumor proteases (OTUs; 16 members), the ubiquitin C-terminal hydrolases (UCHs; 4 members), the Josephin family (4 members) (27, 28) , and as of late, the motif interacting with ubiquitin (MIU)-containing novel DUB family [MINDYs; 4 members (30) ] (see the sidebar titled MINDY, the Sixth DUB Family). In addition, a family of Zn-dependent JAB1/MPN/MOV34 metalloprotease DUBs ( JAMMs, also known as MPN+; 16 members) exists (27, 28) . Other protease classes act on ubiquitin-like modifiers such as SUMO [SENP (sentrin/SUMO-specific protease) and DeSI (deSUMOylating isopeptidase) families] or NEDD8 [NEDP1 (NEDD8-specific protease 1), a SENP family member], and are referred to as ubiquitin-like proteases (ULPs) (31, 32) . The players of the ubiquitin (Ub) system. The Ub system engages functionally distinct protein types, presented here as differently colored game cards showing some key features. The assembly machinery (green cards) writes the Ub code, utilizing E1, E2, and E3 enzymes (reviewed in . Ub signals are recognized by UBDs ( yellow cards), which are referred to as readers of the code (reviewed in Reference 26). DUB and ULP classes (red cards), the erasers of Ub and ubiquitin-like (Ubl) modifications, are compared in detail with regard to enzymatic and structural characteristics. The number of active and inactive members (i.e., proteins lacking catalytic residues or annotated as pseudogenes), protease types, and substrate preferences are given according to the legend. Abbreviations: AMSH-LP, associated molecule with the SH3 domain of STAM (AMSH)-like protein; CSN, COP9 signalosome; DeSI, deSUMOylating isopeptidase; DUB, deubiquitinase; ISG15, interferon-stimulated gene 15; JAMM, JAB1/MPN/MOV34 DUB family; MINDY, MIU-containing novel DUB family; MIU, motif interacting with ubiquitin; NEDD8, neural precursor cell expressed, developmentally downregulated 8; OTU, ovarian tumor protease; SENP, sentrin/SUMO-specific protease; SUMO, small ubiquitinrelated modifier; UBD, ubiquitin-binding domain; UCH, ubiquitin C-terminal hydrolase; UIM, ubiquitin-interacting motif; ULP, ubiquitin-like protease; USP, ubiquitin-specific protease.
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MINDY, THE SIXTH DUB FAMILY
The MINDY family was recently identified as a sixth DUB class that is highly conserved throughout eukaryotes (30) . Initially, the two tandem MIUs of the unstudied protein FAM63A, the founding member of this family now referred to as MINDY-1, were found to be Lys48-specific UBDs (30, 51) . A neighboring domain of unknown function, now termed the MINDY domain, was subsequently shown to exhibit DUB activity with an exquisite selectivity toward Lys48-linked chains. This linkage specificity is conserved in FAM63B/MINDY-2 and FAM188A/MINDY-3 as well as in a yeast ortholog (MINDY in yeast, MIY1). Interestingly, full-length MINDY-1 shows a high preference for long Lys48 chains, which is accompanied by a remarkable exo-activity, cleaving polyubiquitin only from the distal end. Structural studies have shown that the MINDY domain adopts a unique fold within the cysteine protease superfamily (Figure 2) . A covalent MINDY-1-ubiquitin complex shows a surprising binding mode, in which the S1 site appears to enable ubiquitin binding in two alternative conformations. Substrate-induced conformational rearrangements remodel the active site. It will be important to elucidate biological functions and regulation of this interesting new DUB family. Within the ∼100 DUBs in human cells, abundance and expression patterns vary. A census of ubiquitin-regulating proteins in selected cell lines discussed the most abundant mammalian DUBs (33), many of which are part of ubiquitin-regulating cellular machines-the proteasome, the COP9 signalosome (CSN), the p97 AAA+ ATPase (also known as VCP; Cdc48 in yeast), the linear ubiquitin chain assembly complex (LUBAC), and the Spt-Ada-Gcn5 acetyltransferase (SAGA) complex. Many of the most abundant DUBs have been characterized in great detail, and several are discussed below.
HOW TO TARGET A UBIQUITIN OR UBIQUITIN-LIKE SIGNAL
DUBs remove ubiquitin modifications from proteins, and just exactly how they are doing this has been extensively studied in the last decade. Biochemical studies in particular have enabled a detailed conceptualization of the distinct layers of DUB activity and specificity, as summarized in Figure 3 . It is important to consider how DUBs select which modifier to target, how DUBs approach their substrate, and where DUBs cleave ubiquitin chains. Considering the newly emerging complexity of the ubiquitin code (Figure 1b) , it appears that some DUB activities (e.g., DUBs that regulate phosphoubiquitin) are missing and remain to be uncovered.
What to Cleave: Ubiquitin Versus Ubiquitin-Like Modifiers
Ubiquitin-like modifiers such as SUMO, NEDD8, and ISG15 modify lysine residues in proteins by utilizing assembly mechanisms similar to those seen in ubiquitination (23) . The modifiers comprise ubiquitin-like folds (two ubiquitin-like domains in tandem, in the case of ISG15) (Figure 3a) , and NEDD8 and ISG15 even feature C-terminal motifs that are either similar or identical to ubiquitin, respectively (SUMO shares only the common Gly-Gly motif ) (28) . However, overall sequence similarity between ubiquitin and SUMO, NEDD8, or ISG15 is limited. The resulting differences in surface properties enable DUBs and ULPs to distinguish between the modifiers, usually with high specificity (Figure 3a) (34) .
The catalytic domains of DUBs and ULPs recognize the modifier through a primary recognition site, the S1 site (Figure 3a ; see also Section 4.1). Structural work has illuminated the molecular interactions of all DUB families with ubiquitin bound to the S1 site (28, 30) and rationalized why the vast majority of DUBs are ubiquitin specific: In addition to recognition of the ubiquitin C terminus (where DUBs catalyze hydrolysis), surfaces on ubiquitin, including the hydrophobic Ile44 and Ile36 patches (2), mediate DUB interactions. Differences among these hydrophobic surfaces in ubiquitin-like modifiers prevent them from being targeted by most DUBs.
Several USP DUBs can be covalently modified with ISG15-based suicide probes (35) , suggesting that they may be cross-specific. Kinetic studies on one such enzyme, USP21, revealed 80-fold higher DUB activity as compared with deISGylation activity (36) ; it is unclear whether the deISGylation activity is physiologically relevant. Similarly, despite isolated reports that some USPs may be cross-reactive with NEDD8, structural differences in the N terminus and C terminus of NEDD8 as compared with ubiquitin prevent most USPs from binding and cleaving NEDD8 (36) .
Still, striking examples of cross-specificity have been described. Some UCH enzymes target NEDD8 and ubiquitin model substrates with similar activities (37) , and the JAMM family member CSN5 removes NEDD8 from activated cullin-RING E3 ligase (CRL) scaffolds (38) (see Section 5.4.2). USPL1, a USP-fold DUB that lacks key ubiquitin-binding features, was revealed to be a SUMO-specific isopeptidase (39) . Similarly, USP18 is the only known mammalian ISG15-specific isopeptidase (40) , and the molecular basis for its specificity has recently been (41) . It appears that these DUBs have evolved to recognize the distinct features of other modifiers. A rich resource for cross-specific DUBs is presented by enzymes from pathogenic viruses and bacteria (34, 42) . These effector DUBs help subvert immune surveillance mechanisms that rely on ubiquitin and ubiquitin-like modifications. Molecular details of ubiquitin/ISG15 (43) and even ubiquitin/SUMO cross-specificity (42) highlight the adaptability of DUBs to target distinct modifiers.
How to Approach the Substrate: Via the Ubiquitin (Chain) Versus the Target Protein
DUBs regulate ubiquitin modifications on proteins in fundamentally different ways, namely by binding to a protein substrate that they deubiquitinate or by directly binding to a ubiquitin signal that they cleave (Figure 3b; see below) . In addition, some of the most abundant DUBs work as parts of macromolecular machines (e.g., the proteasome), which recruit substrates for deubiquitination. In these complexes, DUB-substrate interaction is indirect and may not be determined by the DUB itself. Aspects of regulation for DUBs in macromolecular assemblies are described at the end of this review (Section 5.4).
Numerous DUBs directly bind target proteins, and this interaction enables DUBs to selectively regulate cellular pathways and processes. With few exceptions, USPs feature additional proteinprotein interaction domains outside or, strikingly, also as insertions within their catalytic domains (27, 44) . These domains are able to recruit substrates for deubiquitination, and most USPs remove ubiquitin from their substrates regardless of linkage type or architecture (45, 46) . USPs commonly also take off the substrate-bound proximal ubiquitin (Figure 1a) , regenerating an unmodified protein.
A completely different picture arises for DUBs that target selected chain types. These enzymes are able to regulate the abundance of distinct linkage types but are often less concerned with the substrate. Mechanisms of linkage specificity are discussed in detail in Section 4.3, but the recognition of a particular chain type principally requires linkage-specific enzymes to bind two ubiquitin moieties across the active site. This requirement entails that linkage-specific DUBs generate monoubiquitinated substrates, and they are indeed typically unable to hydrolyze the isopeptide bond between substrate and proximal ubiquitin. A good example for a linkage-specific DUB is OTULIN (OTU DUB with linear linkage specificity) (47, 48) , which exclusively targets Met1-linked chains (also known as linear chains) as explained below (Sections 4.3 and 5.3.2). In cells, Met1-linked polyubiquitin is eliminated when OTULIN is overexpressed, yet substrates such as NEMO [nuclear factor κB (NF-κB) essential modulator] remain monoubiquitinated (47).
Where to Cleave: Exo-Versus Endo-DUB Activity
Ubiquitin signals present DUBs with several potential points of attack, and where the chain is processed matters (Figure 1a) . Of the three distinct scenarios depicted in Figure 3c , endo-cleavage activity is efficient in clearing ubiquitin from a substrate and releases an unanchored chain that has to be further processed to regenerate monoubiquitin. In contrast, exo-cleavage directly produces monoubiquitin, yet the DUB needs to act multiple times to remove an entire polyubiquitin chain.
Whether a DUB cleaves with endo-or exo-activity depends on both the DUB family and the linkage type. For instance, this difference is illustrated in USP21. A ubiquitin molecule bound to the S1 site of USP21 features a solvent-exposed Lys63 residue that can be distally extended, enabling endo-cleavage of Lys63-linked chains (36) . In contrast, Lys6 of the distal ubiquitin is 166 Mevissen · Komander located at the DUB interface and cannot be extended, imposing exo-cleavage of Lys6-linked chains. Consistently, USP21 processes Lys6 polyubiquitin exclusively from the distal end (10) while cleaving Lys63 chains at any linkage (36) . In other words, despite similar diubiquitin cleavage rates (36) , USP21 has to act four times to remove Lys6 tetraubiquitin, whereas a single cleavage event can erase an entire Lys63 tetraubiquitin signal from the same substrate.
Hence, whether a DUB performs endo-or exo-cleavage depends on how it recognizes polyubiquitin. To enable endo-cleavage, the DUB needs to accommodate a distally extended chain. Most OTU DUBs bind ubiquitin via the S1 site such that all lysine residues are available for chain extension (49) and consequently display endo-activity. Interestingly, OTUD2 and OTUD3 feature additional S2 sites to impose endo-cleavage (49, 50) (see Section 4.4). In contrast, MINDY-1 cleaves Lys48 linkages with exo-activity from the distal end (30) . Additional Lys48-specific UBDs in MINDY-1 (51) may act as S2 /S3 sites (see Section 4.4) and may generate substrates that still have (shorter) ubiquitin chains attached. A different exo-DUB activity is present in USP5 (also known as IsoT), and this enzyme hydrolyzes unattached polyubiquitin from the proximal end (52, 53) (Figure 3c ; see also Section 5.3.3).
Special Cases: Emerging Areas In Which DUB Activities Are Missing
Recent insights into specialized forms of ubiquitination-for example, ubiquitin chain branching, SUMO-ubiquitin hybrid chains, and ubiquitin phosphorylation or acetylation-suggest that new DUB activities are yet to be uncovered (Figure 3d ).
To deal with ubiquitin branch points specifically, above-mentioned considerations of how DUBs recognize chains become very important. Branched modifications could prevent endoDUBs from accessing internal linkages, because the ubiquitin bound to the S1 site would be modified on multiple positions. In the few studies that have analyzed branched ubiquitin chains in vitro, DUBs, perhaps surprisingly, showed no marked decrease in activity (10, (54) (55) (56) (57) . It is still conceivable that physiological cases of chain branching inhibit or delay DUB action. At this point, it is unclear how much of the cellular ubiquitin pool has multiple ubiquitin attachments and whether DUBs exist that specifically act on branched ubiquitin chains.
Similarly, chemical posttranslational modifications of ubiquitin may impact DUB activity. Modeling suggests that ubiquitin phosphorylation on several sites should affect binding to DUBs. Consistently, short chains or polyubiquitinated substrates containing only Ser65-phosphorylated ubiquitin (21)-and also diubiquitin assembled from Ser20-or Ser57-phosphorylated ubiquitin (22)-are targeted by many DUBs with much lower efficiency. Notably, a phosphoubiquitinspecific DUB was not identified in either study. Whereas phosphoubiquitin-directed DUB activities may exist, the contexts and extent of ubiquitin phosphorylation remain unclear, and the in vitro scenarios may be of limited physiological relevance. One cellular context in which relevance could easily be imagined is in mitochondrial turnover, which involves Ser65-phosphoubiquitin (18, 19) and is regulated by several DUBs, including mitochondrial USP30 (58) . Interestingly, USP30 is less active toward phosphoubiquitin (21) , which appears at odds with its inhibitory role in PINK1 (PTEN-induced putative kinase 1)/Parkin-mediated mitophagy (19) .
Finally, polyubiquitin chains may be modified with SUMO (or other ubiquitin-like modifiers) and vice versa (4, 14, 15) . It is conceivable that specialized DUBs recognize and hydrolyze these conjugates (Figure 3d ). USP7 may target ubiquitinated SUMO2 hybrid chains that accumulate in the nucleus (59), but there is little evidence that USP7 cleaves the ubiquitin-SUMO2 linkage with any selectivity. Novel biochemical tools in the form of defined hybrid chains will be necessary to study this in mechanistic detail. Such reagents could reveal fascinating insights into cross talk between the modifiers. 
HOW DUBS BIND AND CLEAVE (POLY)UBIQUITIN
The different layers of DUB activity ( Figure 3 ) and specificity ( Figure 4 ) depend on the ability of DUBs to recognize ubiquitin. All DUBs have at least one ubiquitin-binding site, the S1 site, that guides the ubiquitin C terminus and the scissile bond into the active site, where hydrolysis ensues ( Figure 5 ). In the case of cleaving diubiquitin, the distal ubiquitin occupies the S1 site, whereas the proximal moiety occupies the S1 site (Figure 4a) . The substrate or ubiquitin providing the modified lysine residue can be bound by the catalytic domain, but this is not a requirement (Figure 4b ). In addition, some DUBs feature additional ubiquitin-binding sites (e.g., S2, S3, S2 , or S3 ). These sites enable interaction between the enzyme and long ubiquitin polymers and may contribute to linkage specificity (Figure 4a,d ).
The S1 Ubiquitin-Binding Site
The S1 site selects the modifier and has been structurally characterized for all DUB classes. The interface between the S1 site and ubiquitin is typically extensive, covering 20-40% of the bound ubiquitin molecule (28) . Biochemical analyses indicate that the S1 site drives formation of the enzyme-substrate complex. Curiously, despite high enzymatic activity, monoubiquitin affinities of DUBs can be in the micromolar range, and despite covering substantial surface areas, the molecular contacts are often polar and mediated by water (30, 49, 60) . These characteristics may increase substrate turnover and prevent product inhibition. When ubiquitin binds to the S1 site, its flexible C terminus is maximally extended and engulfed by the DUB. This requires partial unfolding of compact polyubiquitin architectures (e.g., Lys48-linked chains) (Figure 1a) . The opening of these polymers is enabled by the dynamics within polyubiquitin (61) . Linkage type, length, and likely architecture impact chain dynamics and in turn affect DUB activity (61, 62) .
Hence, a minimalistic DUB that features only an S1 site may indiscriminately remove ubiquitin from a target protein (Figure 4b) . Indeed, although USP domains share similar and conserved S1 sites, the region that would mediate substrate interactions is often featureless and nonconserved. This may explain the linkage and substrate promiscuity of USPs in vitro (21, 36, 45, 46, 63) .
Substrate-Binding Sites in DUB Catalytic Domains
DUB catalytic domains may directly bind ubiquitinated proteins and recognize specific ubiquitination sites in their substrates (Figure 4b) . Site-specific deubiquitination has been studied in only a few cases, partly owing to the lack of available reagents for biochemical study of monoubiquitinated proteins or sequences; recent advances in chemical biology are changing this (64) . One spectacular example resolved the molecular mechanism of histone H2B deubiquitination by the SAGA complex, in which Ubp8 (USP22 in humans) directly recognized chemically monoubiquitinated histone H2B (see Section 5.4.3) (65). Studying how DUBs are targeted to defined monoubiquitination sites may reveal new mechanistic principles for DUB-substrate interactions.
Linkage Specificity in DUBs
Linkage specificity in DUBs has been extensively studied, and ubiquitin-based tools and reagents have enabled detailed mechanistic insights (see sidebar titled Uses of DUBs as Tools). The degree of linkage specificity varies between DUB families; most JAMM metalloproteases are Lys63 specific (46, 66-68), whereas MINDY DUBs are Lys48 specific (30) . UCH and Josephin family 168 Mevissen · Komander S1' site on UBD in cis S1'
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USES OF DUBS AS TOOLS
Linkage-specific DUBs are valuable reagents for ubiquitin chain research and can be exploited in several different ways. The discovery of enzymes targeting certain chain types with high specificity led to the development of Ubiquitin Chain Restriction (UbiCRest) analysis (49, 63) . Therein, ubiquitinated substrates assembled in vitro or in cells are treated with a DUB panel containing specific enzymes. The resulting cleavage patterns and products generated during UbiCRest analysis allow conclusions about the composition and architecture of chains present on the substrate (49, 63) . Furthermore, DUBs are invaluable for the generation of large quantities of pure ubiquitin chains in vitro (10, 55, 56, 93, 198) . Most available enzymatic assembly systems for atypical ubiquitin linkages generate small amounts of other chain types in vitro, and these contaminating chain types can be removed by treatment with linkage-specific DUBs to achieve highly pure chains of defined composition.
Finally, inactivated linkage-specific enzymes could be exploited as UBDs to trap, shield, or enrich distinct linkage types. Ubiquitin chain sensors based on UBDs are already important reagents; however, not all linkage types can be discriminated (199, 200) . The development of DUB-based sensors might expand the toolkit of such reagents even further. enzymes show only weak or no activity toward diubiquitin (46, 69) , whereas ATXN3 may prefer long, heterotypic ubiquitin chains (70) .
Although most USPs show little or no linkage preference (36, 45, 46, 69) (see Section 4.1), a small subset has evolved this property. CYLD (cylindromatosis-associated DUB), a tumor suppressor implicated in NF-κB signaling (71), preferentially processes Lys63-and Met1-linked chains (69, 72, 73) , whereas the mitochondrial DUB USP30 prefers Lys6 polyubiquitin (21, 58, 74) .
The most intriguing DUB class with regard to linkage specificity is the OTU family, members of which encode distinct preferences toward one or a small subset of linkage types (49) . Indeed, OTUs were instrumental in revealing global strategies and mechanisms of linkage specificity (Figure 4c,d ). In addition, many mechanistic insights emerged from crystal structures of DUBs in complex with their preferred diubiquitin substrate. 4.3.1. Defined S1 sites within catalytic domains determine linkage specificity. The simplest cases of linkage-specific DUBs harbor S1 and S1 sites within their catalytic domain (Figure 4a) . The proximal ubiquitin is all important, because its position with respect to the active site determines which lysine residue is presented to the catalytic center (Figure 4b) . Hence, linkage specificity in DUBs is a function of the proximal ubiquitin's orientation at the enzyme. Several linkage-specific DUBs have been characterized in great detail, and their structures have revealed fascinating mechanistic details.
AMSH and AMSH-LP.
The JAMM metalloprotease AMSH (associated molecule with the SH3 domain of STAM) was the first DUB for which linkage specificity was noted (75) , and many JAMMs are Lys63 specific in isolation (46, 67) . Crystal structures of AMSH and AMSH-LP (AMSH-like protein) in complex with Lys63-linked diubiquitin provided the first molecular insights into JAMM mechanism and linkage specificity, and these structures revealed features of both the substrate and the enzyme that generate the observed Lys63-linkage specificity (68, 76, 77 (80) . OTUB1 contains a structurally disordered N-terminal ubiquitin-binding helix that is stabilized upon binding to an E2, such as UBE2N or UBE2D (81) (82) (83) , and this interaction significantly enhances OTUB1 catalytic activity (55, 83) . Importantly, when the E2 enzyme is charged with ubiquitin at its catalytic cysteine, this donor ubiquitin occupies the S1 site of OTUB1 (81, 82) . In such a setting, the E2 cannot participate in ubiquitination reactions (80) (81) (82) . Furthermore, monoubiquitin binds noncovalently to the S1 site of OTUB1, which competes with Lys48 chain hydrolysis (83) . Taken together, OTUB1 not only reverses Lys48 ubiquitination but also serves as a powerful inhibitor of various ubiquitination events by regulating E2-ubiquitin conjugates (80) . OTUB1 possibly acts in part as a buffer or even as a molecular rheostat to sense and regulate cellular free ubiquitin versus ubiquitin-charged E2 concentrations. As discussed in Section 5, OTUB1 is subject to further layers of regulation. Structures of CYLD bound to Lys63-and Met1-linked diubiquitin, the first substrate-bound USP structures, revealed how a β-hairpin loop near the catalytic center provides the S1 site and facilitates linkage specificity by imposing the orientation of the proximal ubiquitin (73) . OTULIN is the only known Met1-specific DUB. It binds Met1-linked chains with high affinity to S1 and S1 sites in a manner that only the N-terminal Met1 residue of the proximal ubiquitin is adjacent to the active site (47, 48) . Importantly, OTULIN further uses a mechanism of ubiquitin-assisted catalysis (Figure 4c) , whereby the proximal ubiquitin moiety directly releases an autoinhibited state of the catalytic center (47) . This mechanism is further described in Section 5.3.2.
Cezanne.
The OTU members Cezanne and Cezanne2 are the only DUBs known to target Lys11-linked ubiquitin chains with high specificity. Cezanne plays roles in NF-κB (88) and HIFα (hypoxia-inducible factor 1α) (89, 90) signaling, yet exactly which substrates are modified with Lys11-linked chains in these pathways is not clear. Recent crystal structures have illuminated Cezanne's mechanism of specificity (57) . Cezanne is autoinhibited in the absence of ubiquitin but is able to bind all chain types via an exposed S1 site. Strikingly, an S1 site is not present unless Lys11 diubiquitin is bound across the active site. Large conformational changes in the OTU domain between unbound and diubiquitin-bound states expose hydrophobic residues that form an S1 site in situ (Figure 4c) . Upon hydrolysis of the isopeptide bond, the S1 site is lost, and the proximal ubiquitin is expelled (57) . The mechanism of Cezanne highlights the potential plasticity in DUBs and suggests that ubiquitin-binding sites may be dynamically remodeled (57).
S1
sites provided by ubiquitin-binding domains. S1 ubiquitin-binding sites can be present on DUB catalytic domains, but they can also be provided by UBDs within the DUB (i.e., in cis) or by UBDs of binding partners (i.e., in trans) (Figure 4c) . The OTU family member TRABID (TRAF-binding domain-containing protein) requires its AnkUBD (ankyrin-repeat ubiquitin-binding domain) for processing Lys29-and Lys33-linked chains preferentially (91) . Similarly, the Lys63 specificity of OTUD1 depends on its C-terminal ubiquitin-interacting 172 Mevissen · Komander motif (UIM) (49) . In both cases, UBDs boost activity toward distinct chain substrates, imposing specificity on nonselective catalytic domains.
Fewer examples are known for S1 sites provided in trans. The Lys63-specific DUBs AMSH and AMSH-LP (68, 75) possess low DUB activity in isolation, which is strongly enhanced by STAM (signal transducing adaptor molecule), a ubiquitin-binding subunit of the ESCRT-0 (endosomal sorting complexes required for transport) complex (75) . The UIM of STAM was suggested to directly interact with the proximal moiety of a Lys63-linked substrate, resulting in AMSH activation by stabilization of the enzyme-substrate complex through an enlarged S1 site (Figure 4c) (92) . Consequently, an AMSH-STAM fusion protein is a highly active Lys63-specific enzyme (55) . In contrast to UBDs in TRABID or OTUD1, STAM improves activity but does not need to enhance the already exquisite Lys63 specificity of the AMSH catalytic domain.
Additional Ubiquitin-Binding Sites in DUBs
Numerous DUBs contain UBDs that are not directly involved in DUB activity or specificity but serve to target the enzymes to polyubiquitin chains. In OTUD2 and OTUD3, S2 sites are present within the catalytic domains and promote cleavage of longer (i.e., at least triubiquitin) chains (Figure 4d) (49, 50) . The structure of OTUD2 in complex with Lys11-linked diubiquitin revealed that the ubiquitin chain was bound by an S1 and a previously unknown yet conserved S2 site (49) , which may also exist in OTUD3 (50) . In contrast, S2 sites within catalytic domains have not yet been described. Such sites could be interesting mechanistically, as they may enable DUBs to target branched ubiquitin chains (Figure 4d) .
Other DUBs, including MINDY-1, TRABID, A20, and USP5, feature additional UBDs that contribute to polyubiquitin processing with different mechanisms (Figure 4d) (27, 30) . Although accessory UBDs in TRABID and MINDY-1 bind the same linkage types that the catalytic domain cleaves (30, 55, 93), A20's ZnF (zinc finger) UBDs bind Met1-linked chains that the catalytic core cannot process (49, (94) (95) (96) . Another DUB with several UBDs is USP5, which is described in Section 5.3.3.
MECHANISMS OF DUB REGULATION
The variety of mechanisms for DUBs to interact with ubiquitin and substrates, as described above, enable a plethora of regulatory mechanisms to fine-tune DUB function. Indeed, owing to their role as key enzymes in regulating all ubiquitin-dependent processes, their abundance, localization, and catalytic activity are tightly regulated to ensure appropriate responses (97) . Deregulation can have dramatic physiological consequences and can cause a variety of diseases. DUBs have been genetically linked to cancer as oncogenes and tumor suppressors (98) , to inflammatory diseases (99), and to neurodegeneration (100).
Mechanisms of DUB regulation can be globally classified into (a) the regulation of DUB abundance and localization and (b) the regulation of DUB catalytic activity (Figure 6 ). Some principles, such as the use of PTMs, posttranslational processing, or accessory domains and binding proteins, have been implicated in all aspects of DUB regulation. Importantly, the layers of regulatory mechanisms are interwoven and can act together. Mechanisms of deubiquitinase (DUB) regulation. Principles of DUB regulation can be globally classified into the regulation of DUB abundance and localization and the regulation of DUB catalytic activity. Several mechanisms modulate both aspects. Types of posttranslational modifications discussed include hydroxylation (OH), phosphorylation (P), ubiquitination (Ub), and SUMOylation (S). Abbreviation: ROS, reactive oxygen species.
Regulation of DUB Abundance
tissue-dependent manner (33) , and although some enzymes are highly abundant (e.g., UCH family enzymes in neurons), others are present at rather low levels (e.g., USP30) (33) . DUB expression can be induced in a stimulation-dependent manner. A prime example is A20, which was discovered as a tumor necrosis factor (TNF)-induced gene. Its levels in unstimulated cells are low yet rise substantially upon NF-κB activation, in which it acts as a negative feedback regulator (101, 102) . Intriguingly, once expressed, DUBs can undergo proteolytic processing. A20 protein levels can be regulated by the paracaspase MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1), which cleaves A20 between the N-terminal catalytic OTU domain and the Cterminal UBDs, thereby impairing A20 function (103) . Another NF-κB-regulating DUB, CYLD, is processed by MALT1 as well, while it can also be targeted by caspase-8 (104) (105) (106) . CYLD has a C-terminal catalytic domain, and the cleaved protein is destabilized by the N-end rule pathway (107) . A distinct mechanism of autoprocessing occurs in USP1, which cleaves itself upon UV radiation at a conserved Gly-Gly motif within the USP domain, resulting in USP1 degradation (108) . These examples highlight that DUB abundance can be regulated in specific, situation-dependent ways to impact cellular function.
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Regulation of DUB Localization
A second factor regulating DUB function is subcellular localization. A survey of the location of ∼70 GFP-tagged DUBs in cells revealed varied, DUB-specific distribution all over the cell (109) . DUB localization is achieved by many mechanisms described for other proteins-for example, through targeting domains to interact with distinct cellular membranes, organelles, or cytoskeletal components, localization signals, and protein interaction domains that recruit DUBs to defined complexes.
DUB localization can be modulated by a variety of means. Phosphorylation of OTUB1 and ATXN3 by casein kinase 2, or of USP10 by the kinase ATM (ataxia-telangiectasia mutated), results in nuclear localization of the respective DUB (110) (111) (112) , whereas Akt (RACalpha serine/threonine-protein kinase)-mediated phosphorylation excludes USP4 from the nucleus (113) . Multi-monoubiquitination of the BAP1 (BRCA1-associated protein 1) nuclear localization signal by UBE2O also impairs nuclear import but is counteracted by autodeubiquitination (114) .
Localization can also be affected by changing the protein interactions that a DUB engages in. Hydroxylation of OTUB1 by FIH (factor inhibiting HIF) alters the OTUB1 interactome and substrates (115) , autodeubiquitination of USP4 regulates its interactome as well as its roles in the DNA damage response (116) , and binding of OTULIN to LUBAC is blocked by OTULIN phosphorylation (117, 118).
Regulation of DUB Catalytic Activity
Modulation of protein abundance or localization as described in Sections 5.1 and 5.2 are global mechanisms for the establishment of cellular signaling networks. Alternatively, or in addition, the catalytic DUB activity can be directly regulated in a variety of ways. Distinct mechanisms have evolved to precisely tune catalytic turnover and ubiquitin chain recognition (Figure 6 ).
5.3.1.
Changing DUB activity by posttranslational modifications. The cross talk between the ubiquitin system and other PTMs is a key feature in the adjustment of catalytic DUB activity, and research in recent years has shed light on the extent and elegance of such regulation. 5.3.1.1. Phosphorylation. Phosphorylation can modulate DUB activity positively or negatively. USP8 is inhibited by phosphorylation-dependent association of 14-3-3 proteins, and dephosphorylation in M phase enhances USP8 activity (119) . Somatic mutations within the 14-3-3 binding motif also enhance USP8 activity, resulting in upregulation of epidermal growth factor (EGF) receptor signaling and causing Cushing's disease (120) . Phosphorylation also inactivates the p97-associated DUB VCPIP (valosin-containing protein p97/p47 complex-interacting protein) in early mitosis, and dephosphorylation after mitosis reactivates VCPIP and facilitates Golgi reassembly (121) .
CYLD activity is controlled by phosphorylation in positive and negative ways. Although the IκB kinase (IKK) family members IKKγ (122) and IKKε (123) mediate inhibitory phosphorylation, respectively, IKKβ phosphorylation was shown to activate CYLD (124) . IKKβ also modifies A20 (125) , and this modification increases A20 activity toward Lys63-linked chains (96), which are not cleaved by an unphosphorylated enzyme (49, 126) . Exact mechanisms of CYLD or A20 regulation by phosphorylation are unclear, but it is interesting to note that the reported regulatory phosphorylation sites lie just outside their respective catalytic domains.
DUB phosphorylation within the catalytic domain can also enhance DUB activity. CDK2 (cyclin-dependent kinase 2)-mediated phosphorylation of USP37 regulates activity in a cell www.annualreviews.org • Mechanisms of Deubiquitinase 175 cycle-dependent manner (127) , and Akt-mediated phosphorylation of USP14 may release autoinhibition (128) . The best understood case of phosphorylation-induced DUB activity is OTUD5/DUBA, a regulator of interleukin production in T cells (129) . The enzyme is activated by phosphorylation of Ser177 in the catalytic domain. A crystal structure of phosphorylated OTUD5 in complex with ubiquitin revealed how the phosphorylated loop folds over the ubiquitin C terminus to stabilize the enzyme and exclude water from the active site (130) (Figure 7a) . However, how OTUD5 mediates substrate turnover is unclear, as this would require dynamic opening and closing of the seemingly tight phosphorylation-induced contact. Still, this example again nicely highlights the regulatory capabilities and plasticity in DUBs.
5.3.1.2. Ubiquitination. As discussed above (Figure 4) , DUBs have at least one, but often multiple, ubiquitin-binding sites. Deubiquitinases are also ubiquitinated, in particular when in complex with E3 ligases, and covalently attached ubiquitin can compete with binding of ubiquitinated substrates. For instance, UCH-L1 is monoubiquitinated at lysine residues surrounding the active site, including Lys157 of the crossover loop (131), whereas USP30 is ubiquitinated by Parkin at lysine residues within the fingers subdomain (58) , which may regulate catalytic activity.
In contrast, monoubiquitination of the Josephin domain of ATXN3 enhances enzymatic activity (132) by inducing an activating conformational change (133) . The conjugated ubiquitin has been suggested to rest in the S1 site (134) , but the exact activation mechanism remains unclear.
SUMOylation.
The c-Myc-stabilizing oncogenic DUB USP28 (135) and its relative USP25, which is upregulated after viral infection (136) and regulates toll-like receptor and interleukin signaling (137, 138) , are pharmacologically interesting enzymes regulated by SUMO modifications (139, 140) . In USP25, three N-terminal UBDs modulate DUB activity, and monoubiquitination of Lys99 located at the beginning of a UIM activates the enzyme (141) . Importantly, this region also harbors a SUMO-interacting motif (SIM), and Lys99 and Lys141 can be SUMOylated. Although SUMOylation did not affect processing of a monoubiquitin substrate, it impaired tetraubiquitin binding and cleavage (139) . These observations suggest a role for the UIMs in poly- Structural insights into DUB activity modulation. Selected DUB regulation mechanisms are exemplified by crystal structures. Colored bars match the colors used for the respective mechanisms in Figure 6 . DUBs (blue), ubiquitin (Ub) moieties ( yellow), and external factors (red or green) are shown, and active sites are indicated. (a) Structure of Ser177 phosphorylated OTUD5 bound to Ub (PDB code 3tmp) (130) . (b) A20 OTU domain featuring reduced or differently oxidized states of the catalytic Cys103 residue (PDB codes 3zjd, 3zje, 3zjf, and 3zjg, respectively) (144) . (c) Catalytically inactivated OTULIN (C129A) in complex with Met1-linked diubiquitin reveals the basis of Ub-assisted catalysis (PDB code 3znz) (47) . (d) Ubiquitin complex of full-length USP5 (PDB code 3ihp) (146) . (e) Allosteric regulation of USP12 by the WD40 repeat-containing factors UAF1/WDR48 and WDR20 (PDB code 5k1c) (158) . A Ub molecule is shown in the S1 site for orientation purposes. This structure does not include the SUMO-like domain of UAF1, which would extend to the top. ( f ) UCH-L5 apo structure (PDB code 3a7s) (201) , and complex structures with DEUBAD domains of INO80G that inactivates UCH-L5 (left) and RPN13 that activates UCH-L5 (right) (PDB codes 4uf5 and 4uem, respectively) (167) . The crossover loop is highlighted and plays an important role in the activation mechanism. Abbreviations: DEUBAD, DEUBiquitinase ADaptor domain; DUB, deubiquitinase; INO80G, INO80 complex subunit G; OTU, ovarian tumor protease; OTULIN, OTU DUB with linear linkage specificity; PDB, Protein Data Bank; SUMO, small ubiquitin-related modifier; UAF1, USP1-associated factor 1; UBA, ubiquitinassociated domain; UBP, ubiquitin-binding protein; USP, ubiquitin-specific protease; WDR, WD40 repeat-containing protein. (141) . Similar mechanisms may be in place for USP28 (140) . Another DUB that is subjected to inhibitory SUMOylation is CYLD, in which SUMOylation in the N terminus inactivates the C-terminal catalytic domain (142) . As for CYLD phosphorylation (see Section 5.3.1.1), the underlying mechanisms of inhibition remain elusive.
Together, these examples highlight how PTMs can directly affect DUB activity. Many enzymes are targeted within or outside their catalytic domain, but owing to the plasticity of DUBs it is difficult to predict whether any such modification will be inhibitory or activating. These modulations of catalytic activities will need to be tested experimentally. 3.1.4 . Oxidation. The majority of DUBs are cysteine proteases (Figures 2 and 5a) and feature a reactive cysteine residue that is susceptible to oxidation. Consequently, oxidation by reactive oxygen species (ROS) has been shown to inactivate members of the OTU, USP, and UCH families in vitro and in vivo (143) (144) (145) . Importantly, oxidation events may be reversible. A series of high-resolution A20 structures in different oxidized states revealed how normally unstable hydroxylation intermediates [cysteine sulfenic acid (SOH)] are stabilized by interactions within the OTU domain (Figure 7b ) (144) . This stabilization protects A20 from immediate irreversible oxidation [i.e., from further oxidation to sulfinic (SO 2 H) or sulfonic (SO 3 H) acid] and enables regulation in a range of cellular ROS concentrations. It was proposed that cysteine-based DUBs serve as ROS sensors and that reversible inhibition is critical for fine-tuning cellular stress responses (143-145).
5.

Substrate-assisted catalysis.
We discussed above how DUBs achieve linkage specificity by binding to two ubiquitin moieties across the active site (Figure 4c) . Many DUBs exploit differences in substrate binding to distinguish chain substrates, and hence specificity is a function of the Michaelis constant (K M ) of the enzyme. In some intriguing examples, however, linkage specificity is determined by the turnover number (k cat ), suggesting distinct mechanisms. In these instances, substrate binding directly leads to enzyme activation, enabling exquisite control of linkage specificity.
This mechanism was first uncovered in OTULIN. In addition to preferential binding of Met1-linked diubiquitin [K d of 120 nM, compared with 12 μM for Lys63 diubiquitin (47) ], OTULIN is unable to cleave Lys63-linked chains even at high enzyme concentrations. Crystal structures of OTULIN showed that the enzyme is directly activated by Met1 diubiquitin (Figure 7c) (47, 48) . Glu16 of the proximal ubiquitin resolves an inhibitory conformation and aligns the catalytic triad. Consistent with a substrate-assisted mechanism, mutation of this residue does not impair chain binding but prevents chain hydrolysis (240-fold reduction in k cat ). Hence, OTULIN uses a mechanism of ubiquitin-assisted catalysis (47) .
Similarly, Cezanne relies on k cat activation by Lys11 diubiquitin (57) . In contrast to OTULIN, Cezanne invokes large conformational rearrangements during the catalytic cycle, in which the S1 site is formed only when the correct polyubiquitin interacts with the S1 site (see Section 4.3.1.4). A key interaction between Lys33 of the proximal moiety in Lys11 diubiquitin and Cezanne affects turnover and determines linkage specificity (57).
Allosteric regulation of DUB activity.
In addition to posttranslational modifications, DUB performance can be directly modulated in an allosteric fashion, involving accessory domains in cis or regulatory factors in trans. 178 Mevissen · Komander 5.3.3.1. Via accessory domains. The intrinsic DUB activity of catalytic domains is often allosterically modulated by domains within the enzyme or by binding partners. The role of UBDs in providing chain targeting and linkage specificity has already been discussed ( Figure 4) ; however, in some cases, UBDs have additional, allosteric roles.
USP5 serves an important role in clearing unanchored polyubiquitin from cells, and this function is facilitated by several UBDs: two ubiquitin-associated (UBA) domains provide S2 and S3 sites, and a C-terminal ZnF-UBP (hereafter referred to as cUBP) domain acts as an S1 site to enable specific interactions with unattached ubiquitin chains, promoting proximal exo-cleavage (Figure 3c) (52, 53, 146) . In contrast, the N-terminal ZnF-UBP (nUBP) of USP5 boosts its isopeptidase activity in an allosteric fashion (146) . In the crystal structure of full-length USP5, this domain is tightly bound to the catalytic USP core (Figure 7d) , and although it does not bind ubiquitin, its removal results in a >1,000-fold reduced activity toward ubiquitin-AMC (7-amido-4-methylcoumarin) (146) . ZnF-UBP domains exist in 12 human USPs (27) and may serve similar allosteric roles in other members.
Another well-studied case of DUB regulation via internal domains exists in USP7/HAUSP (herpesvirus-associated USP). The last two of five HAUSP ubiquitin-like domains (HUBLs), together with a C-terminal peptide (CTP), enhance USP7 activity 100-fold by binding back to the so-called switching loop in the USP domain, which increases both k cat and K M (147) . Structural work has illustrated how HUBLs and CTP regulate USP7 and stabilize a catalytically competent conformation (148, 149) . In addition, the first three HUBL domains (HUBL-123) are also important for GMP synthetase (GMPS)-dependent USP7 hyperactivation (147, 149, 150) . GMPS associates with HUBL-123, resulting in an enhanced activation by HUBL-45 and the CTP. This mechanism provides a nice example of how DUBs can be regulated allosterically.
Via activating or inhibiting proteins in trans.
DUBs often do not act in isolation but as part of protein complexes. A key resource in DUB research is the DUB interactome from the Harper laboratory (151) , which has identified many regulators.
One of the most striking examples of DUB regulation is the activation of several USPs by WDR (WD40 repeat)-containing proteins. USP1, USP12, and USP46 are allosterically activated by UAF1 (USP1-associated factor 1, also known as WDR48) (152, 153) , and USP12 and USP46 are synergistically stimulated by another WD40 repeat protein, WDR20 (154) . USP1 regulates the Fanconi anemia DNA repair pathway by targeting ubiquitinated FANCD2 (Fanconi anemia group D2 protein) and PCNA (proliferating cell nuclear antigen) (108, 155) . UAF1 not only enhances USP1 catalytic activity through a k cat -driven mechanism (152) but also recruits FANCD2 and PCNA substrates via a SUMO-like domain (SLD) that interacts with a SUMO-like interacting motif (SLIM) in its substrates (156) .
A series of complex crystal structures for USP46 (157) and USP12 (158, 159) uncovered how UAF1 contacts the USP fingers subdomain while WDR20 binds below the palm subdomain (Figure 7e) . The structures suggest how SLD-SLIM interactions may present ubiquitinated substrates to the catalytic domain. Surprisingly, both regulators bind far away from the catalytic center. The observed allosteric activation of enzyme turnover is based on a combination of the stabilization of flexible elements and numerous subtle structural changes, which translate into the active site (157) (158) (159) . USP1 forms similar interactions with UAF1 and is likely regulated by an analogous mechanism; in contrast to USP12 and USP46, USP1 contains two large insertions in its USP domain (44) that may invoke additional regulatory mechanisms (such as self-cleavage, see Section 5.1). Notably, small-molecule inhibitors of USP1 have been identified that may act by preventing UAF1-mediated USP1 activation (160) . Targeting regulatory interactions represents an attractive route to achieve DUB-specific inhibitors.
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Other allosteric activators may employ similar strategies. The binding site for WDR20 may also be utilized by SPATA2 (spermatogenesis-associated protein 2), which was recently shown to mildly (2-to 3-fold) stimulate CYLD activity (87, 161) . Here, DUB activation may be a side effect; SPATA2's role as a bridge between CYLD and the LUBAC complex may be functionally more important (87, (161) (162) (163) .
Intriguing examples of positive and negative activity modulation by interacting proteins are seen in the UCH family. UCH-L5/UCH37 associates with the proteasome regulatory particle and is activated by the subunit RPN13. UCH-L5 is also part of the INO80 chromatin-remodeling complex, yet in this complex the DUB is inhibited (164, 165 ). An underlying regulatory domain, identified and named the DEUBAD (DEUBiquitinase ADaptor) domain (166) , enabled structural characterization (167, 168) . Interestingly, the INO80G DEUBAD domain sterically occludes the S1 site and prevents substrate binding, whereas RPN13 binds in a different manner and enhances DUB activity by promoting the DUB-ubiquitin interaction (Figure 7f ). An analogous mechanism applies to the closely related tumor suppressor BAP1 that requires DEUBAD-mediated activation to process monoubiquitinated histone H2A (169) . Together, these examples highlight the diversity by which intrinsic domains or external partners regulate DUB catalytic activities.
Regulation of DUBs in Macromolecular Complexes
5.4.1. Proteasomal DUBs. Allosteric activation mechanisms also occur for DUBs that are integral parts of large macromolecular assemblies. At least three DUBs interact with the proteasome, namely UCH-L5 (discussed above), USP14 (Ubp6 in yeast), and the JAMM family DUB RPN11. These enzymes have distinct roles that are tightly coupled with substrate engagement by the AAA+ ATPase ring that guards the entry into the proteasome. USP14 functions in preprocessing incorrectly ubiquitinated proteins for proteasomal degradation by targeting substrates with multiple ubiquitin chains (170) . Initial structural work revealed an autoinhibited USP14 apoenzyme (171) , which is indeed catalytically inactive and requires binding to the proteasome for a >800-fold activation (172, 173) . Once bound, USP14 facilitates orderly substrate degradation via numerous allosteric changes within the proteasome lid (174) . Many details of these mechanisms and of USP14 activation emerged from high-resolution cryo-electron microscopy studies (Figure 8a) (174) (175) (176) .
RPN11 is activated by proteasome incorporation and ATP hydrolysis (177, 178) . It is located directly above the entry channel of the 20S proteasome core, where it forms tight contacts with an inactive JAMM-fold protein, RPN8 (Figure 8a) (176, 179, 180) . RPN11 hence targets the DUBs as key regulators of macromolecular complexes. (a) Cryo-electron microscopy structure of the human 26S proteasome (PDB code 5gjq) (176) . The overview (left) depicts the 20S core (black) and the 19S regulatory particle (gray), including the DUBs Rpn11 and ubiquitin (Ub)-bound USP14 (blue). A Ub molecule in the Rpn11 S1 site was modeled on the basis of JAMM-Ub complexes. USP14 recruitment involves three surface loops, including blocking loops BL1 and BL2 (close-up, middle). Rpn11 is closely associated with Rpn8, and the targeted Ub might be further contacted by additional proteasome subunits (close-up, right). (b) Complex between CSN ( gray) and its substrate, NEDDylated CRL4A (black), determined by cryo-electron microscopy (188) . The catalytic component CSN5 (blue) is tightly regulated by CSN6 and other CSN subunits (close-up, right). (c) Crystal structure of the SAGA DUB module in complex with monoubiquitinated nucleosome (gray; PDB code 4zux) (65) . The USP enzyme Ubp8 (blue) directly contributes to the recognition of modified histone H2B (close-up, right). Abbreviations: CRL, cullin-RING E3 ligase; CSN, COP9 signalosome; CUL4A, cullin-4A; DDB1, DNA damage-binding protein 1; DUB, deubiquitinase; NEDD8, neural precursor cell expressed, developmentally downregulated 8; PDB, Protein Data Bank; RBX1, RING-box protein 1; SAGA, Spt-Ada-Gcn5 acetyltransferase; Sgf, SAGA-associated factor; USP, ubiquitin-specific protease. proximal ubiquitin on a to-be-degraded substrate and removes ubiquitin chains en bloc. Structures of the RPN11-RPN8 dimer consistently show that RPN11 lacks an S1 site and that pulling on the substrate by the ATPase subunits may lead to DUB activation (181, 182) . Finally, a proteasome lid structure further determined how RPN11 is kept inactive within the assembled lid prior to full 26S proteasome assembly (183).
5.4.2.
The deNEDDylase in the COP9 signalosome. The proteasome lid structurally resembles the CSN, and the JAMM-fold proteins CSN5/CSN6 are structural counterparts of RPN11/RPN8, with CSN5 providing deNEDDylation activity (38) . Isolated CSN5 is autoinhibited (184) and only partially activated by heterodimer formation with catalytically inactive CSN6 (185) . CSN5 is also autoinhibited in the substrate-free CSN holoenzyme (186) . An intricate interaction network involving various CSN subunits senses NEDDylated CRLs and releases CSN5 autoinhibition (187, 188) . Structures of CSN bound to NEDDylated CRL1 and CRL4A, respectively, revealed how the CRL substrate is sensed by CSN2 and CSN4 (186) (187) (188) . They also revealed how CRL components and an induced-fit mechanism facilitate CSN6-mediated activation of CSN5 (Figure 8b ) (186) (187) (188) . The architecture of these complexes shows that CSN and ubiquitination substrates compete for CRL binding, suggesting a general regulatory mechanism in which substrate-free CRLs are kept inactive through CSN association and deNEDDylation (12).
DUB complexes in the nucleus.
Large DUB-containing complexes are also present on DNA. BRISC (BRCC36 isopeptidase complex) and BRCA1-A (BRCA1-Abraxas) complexes utilize the JAMM DUB BRCC36 as the catalytic subunit and regulate mitotic spindle assembly (189) and DNA double-strand break repair (190) , respectively. A structural understanding of the architecture of these complexes is starting to emerge (191, 192) . Significantly more is known about the SAGA complex, which is responsible for histone H2B deubiquitination in transcriptional regulation (193, 194) . Activity of the yeast USP Ubp8 (USP22 in humans) depends on its incorporation into the SAGA DUB module (195) , and structural studies explained how the interplay of multiple SAGA subunits stabilizes the DUB (196, 197) . The molecular basis for substrate recognition was provided by the crystal structure of the SAGA DUB module bound to a monoubiquitinated nucleosome (Figure 8c) (65) . This complex revealed that the substrate is contacted not only by the SAGA component Sgf11 but also by the USP domain itself, indicating that Ubp8 may have evolved a histone-specific S1 site (Figure 8c ; see also Section 4.2 and Figure 4b) . Apart from polyubiquitin-bound structures, this complex is one of the first DUB-substrate complexes, and it may serve as a paradigm for other monoubiquitin-targeting enzymes.
CONCLUSIONS
In this review, we have attempted to provide an overview of how deubiquitinases deal with the ever-more-complex ubiquitin code, discussing the many strategies that DUBs exploit to provide the perfect answer to the diverse ubiquitination events in a cell. Initially, the ubiquitin system was considered a blunt tool used to degrade proteins via the proteasome; this view has been superseded in the last decade with the explosion of data on the fine-tuning and intricate regulation that the ubiquitin system utilizes. Traditionally, DUB research has been rich in structure and mechanism, and this is the focus of this review. What is much less developed, but clearly the next frontier in DUB research, is the translation of the mechanistic findings and discoveries into biological systems, the validation of mechanistic aspects of DUBs derived in vitro (such as linkage 182 Mevissen · Komander specificity) in cellular settings, and the use of the gained knowledge to further unravel the ubiquitin code. In particular, the mechanisms of linkage specificity have revealed a global understanding of what is required for a particular chain to be built, recognized, and hydrolyzed. For the authors personally, insights into DUB mechanisms have led to a deep appreciation of the intricacies of polymer biochemistry, which is what ubiquitin research is at its core.
The complexity of the ubiquitin code has prevented full exploitation of the involved enzymes, including DUBs, by the pharmaceutical sector. The improved understanding of DUB mechanism, biochemistry, and eventually biology will hopefully translate into first-in-class inhibitors that can be used clinically-for example, to destabilize oncogenes such as c-Myc that so far have remained undruggable. This would be a wonderful outcome of the considerable and exciting DUB research from past decades.
SUMMARY POINTS
1. DUBs are key regulators of the ubiquitin code that need to deal with highly complex (poly)ubiquitin modifications.
2. The six human DUB families have distinct structural and enzymatic features, and some members are dedicated to ubiquitin-like modifiers.
3. Target-specific DUBs often cannot discriminate between ubiquitin chain types, whereas linkage-specific DUBs use a variety of strategies to target certain linkages.
4. DUB abundance, localization, and catalytic activity are regulated by intricate mechanisms to fine-tune cellular DUB function.
5. Many DUBs do not act in isolation but as part of protein complexes or large molecular machines.
FUTURE ISSUES
1. Have all human DUBs been identified? Other cysteine proteases may be DUBs, and probes targeting metalloproteases, serine proteases, or aspartate proteases might reveal novel DUB classes.
2. Are there DUBs dedicated to debranching or processing of posttranslationally modified ubiquitin chains? It is conceivable that these activities should exist.
3. Can DUBs with novel properties be engineered? Such enzymes might be valuable tools for ubiquitin chain research. 
